Michael Ujiki to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Michael Ujiki has written about Dose-Response Relationship, Drug.
Connection Strength
0.129
-
Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer. 2006 Dec 29; 5:76.
Score: 0.053
-
A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. Biochem Biophys Res Commun. 2006 Feb 24; 340(4):1224-8.
Score: 0.049
-
The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells. Pancreas. 2009 May; 38(4):409-15.
Score: 0.015
-
N-methylsansalvamide a peptide analogues. Potent new antitumor agents. J Med Chem. 2005 May 19; 48(10):3630-8.
Score: 0.012